Tehran University of Medical Sciences

Science Communicator Platform

Share By
Dysregulation of the Immune Response in Coronavirus Disease 2019 Publisher Pubmed



Mohamed Khosroshahi L1 ; Rezaei N1, 2, 3
Authors

Source: Cell Biology International Published:2021


Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can trigger a cytokine storm in the pulmonary tissue by releasing various types of mediators, leading to acute respiratory distress syndrome (ARDS). Increased neutrophil-to-lymphocyte ratio, as well as CD4+ T lymphopenia, is reported in cases with novel coronavirus disease (COVID-19), meanwhile, lymphopenia is a significant finding in the majority of COVID-19 cases with a severe phenotype. Moreover, excessive activation of monocyte/macrophage and cytokine storms are associated with the severity of the disease and the related complications in SARS-CoV-2 infection. Understanding the immune response dysregulation in COVID-19 is essential to develop more effective diagnostic, therapeutic, and prophylactic strategies in this pandemic. © 2020 International Federation for Cell Biology
Related Docs
View other Related Docs
1. Covid-19: From the Molecular Mechanisms to Treatment, Tanaffos (2022)
2. Covid-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions, Frontiers in Cell and Developmental Biology (2021)
3. Coronavirus Disease 2019 (Covid-19): Immune Responses, Transmission, and Clinical Features: An Update, Journal of Cellular and Molecular Anesthesia (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Mohammad Hossein Nicknam (1)
Other Related Docs
4. Towards Treatment Planning of Covid-19: Rationale and Hypothesis for the Use of Multiple Immunosuppressive Agents: Anti-Antibodies, Immunoglobulins, and Corticosteroids, International Immunopharmacology (2020)
5. Interindividual Immunogenic Variants: Susceptibility to Coronavirus, Respiratory Syncytial Virus and Influenza Virus, Reviews in Medical Virology (2021)
6. Immune Mechanisms in the Pathogenesis of Coronavirus Disease 2019, Journal of Cellular and Molecular Anesthesia (2022)
7. The Outlook for Diagnostic Purposes of the 2019-Novel Coronavirus Disease, Journal of Cellular Physiology (2020)
8. Potential Therapeutic Applications of Extracellular Vesicles in the Immunopathogenesis of Covid-19, Pathology Research and Practice (2023)
9. Efficacy of Mrna, Adenoviral Vector, and Perfusion Protein Covid-19 Vaccines, Biomedicine and Pharmacotherapy (2022)
10. Statins: Beneficial Effects in Treatment of Covid-19, Advances in Experimental Medicine and Biology (2023)
11. Current Evidence on the Use of Anakinra in Covid-19, International Immunopharmacology (2022)
12. The Involvement of the Central Nervous System in Patients With Covid-19, Reviews in the Neurosciences (2020)
13. Partners in Crime: Autoantibodies Complicit in Covid-19 Pathogenesis, Reviews in Medical Virology (2023)
14. Therapeutic Strategies for Covid-19 Patients: An Update, Infectious Disorders - Drug Targets (2022)
15. Covid-19 As a Trigger of Guillain-Barre Syndrome: A Review of the Molecular Mechanism, Immunity# Inflammation and Disease (2023)
16. Pharmacotherapy Consideration of Thrombolytic Medications in Covid-19-Associated Ards, Journal of Intensive Care (2022)
17. Spatial Transcriptomics and Single Cell-Rnaseq Reveals Cellular Heterogeneity of Sars-Cov-2 in Lung Tissues and Global Mutational Patterns in Covid-19 Patients, Journal of Medical Virology (2025)
18. The Expression Patterns of Malat-1, Neat-1, Thril, and Mir-155-5P in the Acute to the Post-Acute Phase of Covid-19 Disease, Brazilian Journal of Infectious Diseases (2022)
19. The Role of Cytokines and Their Antagonists in the Treatment of Covid-19 Patients, Reviews in Medical Virology (2023)
20. The Powerful Immune System Against Powerful Covid-19: A Hypothesis, Medical Hypotheses (2020)